CancerLinQ SmartLinQ (RxLinQ & TriaLinQ)
Overview
ConcertAI’s CancerLinQ SmartLinQ (RxLinQ & TriaLinQ) is a precision oncology platform that leverages clinical expertise, real-world data, and applied AI to deliver practical intelligence for oncology and other complex diseases. The platform includes RxLinQ for identifying patients eligible for newly approved therapies and TriaLinQ for patient-to-trial matching, aiming to streamline clinical workflows and support high-stakes decisions in research, treatment, and delivery. It integrates imaging workflows with the broader context of patient care and offers solutions for life sciences and pharma, including real-world evidence, clinical trials, and commercial insights. The platform is built on a vast datalake of millions of patient records used to train its AI, and its data has been utilized in hundreds of scientific publications. ConcertAI collaborates with leading technology and lab partners to integrate deep genomic and molecular insights into real-world clinical intelligence.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- RxLinQ for identifying patients eligible for newly approved therapies
- TriaLinQ for patient-to-trial matching
- AI-driven insights from real-world data
- Integration of clinical and genomic data
- Streamlined clinical workflows
- Support for research, treatment, and delivery decisions
- Enterprise imaging integration (TeraRecon)
- Real-world evidence generation
- Clinical trial design and execution support
- Commercial insights for patient journeys
Use Cases
- Identifying patients for novel cancer therapies
- Matching patients to appropriate clinical trials
- Improving quality of care in oncology
- Generating real-world evidence for life sciences and pharma
- Optimizing clinical trial design and operations
- Understanding patient treatment journeys
Details
| Category | Clinical Decision Support & Reference, Drug Discovery & Research, Oncology AI |
| Pricing | Contact for pricing |
| Deployment | Cloud-based |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | No AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Hematology, Oncology, Pathology |
What the Web Says
CancerLinQ SmartLinQ, encompassing RxLinQ and TriaLinQ, is generally viewed as a valuable tool for oncology practices, aiming to improve patient care through data-driven insights and streamlined clinical trial matching. It leverages real-world data to provide decision support and identify eligible patients for trials, addressing critical needs in cancer treatment and research.
Overall: PositiveStrengths
- Leverages real-world data for improved clinical decision-making.
- Automates identification of eligible patients for clinical trials (TriaLinQ), increasing trial participation.
- Provides insights into treatment patterns and outcomes across a large patient population.
- Aids in medication management and adherence (RxLinQ).
- Developed by ASCO, lending credibility and clinical relevance.
- Potential to reduce disparities in clinical trial access.
Limitations
- Data integration can be complex and time-consuming for some practices.
- Concerns about data privacy and security, although ASCO emphasizes de-identification.
- Requires significant physician engagement and data entry to maximize benefits.
- Cost can be a barrier for smaller practices or those with limited IT budgets.
- Steep learning curve for some users, requiring adequate training and support.
- Limited information available on specific user experiences from independent review sites like G2 or Capterra.
Based on reviews from: CancerLinQ.org, ASCO publications and press releases, Healthcare IT news articles, Physician forums and discussions (general sentiment), Academic papers discussing real-world evidence in oncology
Last updated: 2026-09-29
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate CancerLinQ SmartLinQ (RxLinQ & TriaLinQ)
Videos
Product demos, reviews, and walkthroughs for CancerLinQ SmartLinQ (RxLinQ & TriaLinQ).
Frequently Asked Questions
Compare CancerLinQ SmartLinQ (RxLinQ & TriaLinQ)
VS
VS
VS
